Cargando…
Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice
OBJECTIVE: The gut microbiota is an important influencing factor of metabolic health. Although dietary interventions with probiotics, prebiotics, and synbiotics can be effective means to regulate obesity and associated comorbidities, the underlying shifts in gut microbial communities, especially at...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437638/ https://www.ncbi.nlm.nih.gov/pubmed/30792016 http://dx.doi.org/10.1016/j.molmet.2019.01.012 |
_version_ | 1783406969355239424 |
---|---|
author | Ke, Xinxin Walker, Alesia Haange, Sven-Bastiaan Lagkouvardos, Ilias Liu, Yuwen Schmitt-Kopplin, Philippe von Bergen, Martin Jehmlich, Nico He, Xin Clavel, Thomas Cheung, Peter C.K. |
author_facet | Ke, Xinxin Walker, Alesia Haange, Sven-Bastiaan Lagkouvardos, Ilias Liu, Yuwen Schmitt-Kopplin, Philippe von Bergen, Martin Jehmlich, Nico He, Xin Clavel, Thomas Cheung, Peter C.K. |
author_sort | Ke, Xinxin |
collection | PubMed |
description | OBJECTIVE: The gut microbiota is an important influencing factor of metabolic health. Although dietary interventions with probiotics, prebiotics, and synbiotics can be effective means to regulate obesity and associated comorbidities, the underlying shifts in gut microbial communities, especially at the functional level, have not been characterized in great details. In this study, we sought to investigate the effects of synbiotics on the regulation of gut microbiota and the alleviation of high-fat diet (HFD)-induced metabolic disorders in mice. METHODS: Specific pathogen-free (SPF) male C57BL/6J mice were fed diets with either 10% (normal diet, ND) or 60% (high-fat diet, HFD) of total calories from fat (lard). Dietary interventions in the HFD-fed mice included (i) probiotic (Bifidobacterium animalis subsp. lactis and Lactobacillus paracasei subsp. paracasei DSM 46331), (ii) prebiotic (oat β-glucan), and (iii) synbiotic (a mixture of i and ii) treatments for 12 weeks. Besides detailed characterization of host metabolic parameters, a multi-omics approach was used to systematically profile the microbial signatures at both the phylogenetic and functional levels using 16S rRNA gene sequencing, metaproteomics and targeted metabolomics analysis. RESULTS: The synbiotic intervention significantly reduced body weight gain and alleviated features of metabolic complications. At the phylogenetic level, the synbiotic treatment significantly reversed HFD-induced changes in microbial populations, both in terms of richness and the relative abundance of specific taxa. Potentially important species such as Faecalibaculum rodentium and Alistipes putredinis that might mediate the beneficial effects of the synbiotic were identified. At the functional level, short-chain fatty acid and bile acid profiles revealed that all dietary interventions significantly restored cecal levels of acetate, propionate, and butyrate, while the synbiotic treatment reduced the bile acid pools most efficiently. Metaproteomics revealed that the effects of the synbiotic intervention might be mediated through metabolic pathways involved in carbohydrate, amino acid, and energy metabolisms. CONCLUSIONS: Our results suggested that dietary intervention using the novel synbiotic can alleviate HFD-induced weight gain and restore gut microbial ecosystem homeostasis phylogenetically and functionally. |
format | Online Article Text |
id | pubmed-6437638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-64376382019-04-11 Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice Ke, Xinxin Walker, Alesia Haange, Sven-Bastiaan Lagkouvardos, Ilias Liu, Yuwen Schmitt-Kopplin, Philippe von Bergen, Martin Jehmlich, Nico He, Xin Clavel, Thomas Cheung, Peter C.K. Mol Metab Original Article OBJECTIVE: The gut microbiota is an important influencing factor of metabolic health. Although dietary interventions with probiotics, prebiotics, and synbiotics can be effective means to regulate obesity and associated comorbidities, the underlying shifts in gut microbial communities, especially at the functional level, have not been characterized in great details. In this study, we sought to investigate the effects of synbiotics on the regulation of gut microbiota and the alleviation of high-fat diet (HFD)-induced metabolic disorders in mice. METHODS: Specific pathogen-free (SPF) male C57BL/6J mice were fed diets with either 10% (normal diet, ND) or 60% (high-fat diet, HFD) of total calories from fat (lard). Dietary interventions in the HFD-fed mice included (i) probiotic (Bifidobacterium animalis subsp. lactis and Lactobacillus paracasei subsp. paracasei DSM 46331), (ii) prebiotic (oat β-glucan), and (iii) synbiotic (a mixture of i and ii) treatments for 12 weeks. Besides detailed characterization of host metabolic parameters, a multi-omics approach was used to systematically profile the microbial signatures at both the phylogenetic and functional levels using 16S rRNA gene sequencing, metaproteomics and targeted metabolomics analysis. RESULTS: The synbiotic intervention significantly reduced body weight gain and alleviated features of metabolic complications. At the phylogenetic level, the synbiotic treatment significantly reversed HFD-induced changes in microbial populations, both in terms of richness and the relative abundance of specific taxa. Potentially important species such as Faecalibaculum rodentium and Alistipes putredinis that might mediate the beneficial effects of the synbiotic were identified. At the functional level, short-chain fatty acid and bile acid profiles revealed that all dietary interventions significantly restored cecal levels of acetate, propionate, and butyrate, while the synbiotic treatment reduced the bile acid pools most efficiently. Metaproteomics revealed that the effects of the synbiotic intervention might be mediated through metabolic pathways involved in carbohydrate, amino acid, and energy metabolisms. CONCLUSIONS: Our results suggested that dietary intervention using the novel synbiotic can alleviate HFD-induced weight gain and restore gut microbial ecosystem homeostasis phylogenetically and functionally. Elsevier 2019-02-05 /pmc/articles/PMC6437638/ /pubmed/30792016 http://dx.doi.org/10.1016/j.molmet.2019.01.012 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Ke, Xinxin Walker, Alesia Haange, Sven-Bastiaan Lagkouvardos, Ilias Liu, Yuwen Schmitt-Kopplin, Philippe von Bergen, Martin Jehmlich, Nico He, Xin Clavel, Thomas Cheung, Peter C.K. Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice |
title | Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice |
title_full | Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice |
title_fullStr | Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice |
title_full_unstemmed | Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice |
title_short | Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice |
title_sort | synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437638/ https://www.ncbi.nlm.nih.gov/pubmed/30792016 http://dx.doi.org/10.1016/j.molmet.2019.01.012 |
work_keys_str_mv | AT kexinxin synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT walkeralesia synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT haangesvenbastiaan synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT lagkouvardosilias synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT liuyuwen synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT schmittkopplinphilippe synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT vonbergenmartin synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT jehmlichnico synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT hexin synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT clavelthomas synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice AT cheungpeterck synbioticdrivenimprovementofmetabolicdisturbancesisassociatedwithchangesinthegutmicrobiomeindietinducedobesemice |